Clinical Trial Update: Study of Tetanus and Diphtheria Toxoids Adsorbed Combined With Component Pertussis Vaccine and Inactivated Poliomyelitis [Phase 2]

View source ↗

Summary

Phase 2 trial of a combined tetanus, diphtheria, acellular pertussis, and inactivated poliomyelitis vaccine sponsored by Sanofi Pasteur has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Hepatitis B
• Pertussis
• Poliomyelitis
• Tetanus

Drugs mentioned

• Tetanus and Diphtheria Toxoids Adsorbed Combined With Component Pertussis Vaccine and Inactivated Poliomyelitis (Tetanus toxoid, Diphtheria toxoid, acellular Pertussis component, Inactivated Poliovirus vaccine)

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Pertussis, Tetanus | Phase 2 | Status: COMPLETED